Labcorp Holdings Inc.LH
What Labcorp Holdings Inc. does.
Labcorp ® Holdings Inc. is a global leader of innovative and comprehensive laboratory services that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. The Company provides insights and accelerates innovations to improve health and improve lives through its unparalleled diagnostics and drug development laboratory capabilities. During 2025, the Company’s nearly 71,000 employees served clients in approximately 100 countries and performed more than 750 million tests for patients around the world. In addition, the Company provided support for more than 85% of the new drugs and therapeutic products approved in 2025 by the FDA.
The Company’s strength in science, technology, and innovation, as well as its global scale, powers its continued success, differentiates the Company, and enables it to play a leading role in advancing healthcare across the globe. These strengths are critical to the Company’s ability to carry out its mission to improve health and improve lives.
Through leadership in science, technology and innovation, the Company provides vital information and services to help its customers make clear and confident decisions to improve health and improve lives.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $14.0B | $13.1B | $11.9B | $12.2B | $13.0B | $14.0B |
| Net income | $1.6B | $2.4B | $1.3B | $418.0M | $746.0M | $876.5M |
| Free cash flow | $1.8B | $2.7B | $1.5B | $874.1M | $1.1B | $1.2B |
More on LH.
- Labcorp Holdings Inc. summary
- Labcorp Holdings Inc. financial statements
- Labcorp Holdings Inc. key metrics
- Labcorp Holdings Inc. health scores and style box
- Labcorp Holdings Inc. earnings
- Labcorp Holdings Inc. dividends
- Labcorp Holdings Inc. valuation
- Labcorp Holdings Inc. ownership and insiders
- Labcorp Holdings Inc. peers
Figures from Labcorp Holdings Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.